NewNow you can hear Fox News article!
Exclusive: More than 20 Republican Attorney Generals are demanding that the Trump administration restore the safety protocol for abortion drug mifiprystone, saying that it is “serious risk for women”.
In a letter received by Fox News Digital, 22 Attorney General Robert F. Kennedy Junior and Food and Drugs Administration head Martin Makeri called Obama and Biden administration to bring back security measures for filtering bullets.
“Chemical miscarriage drug drug mifiprystone’s recent extensive studies reports that severe adverse events occur 22 times more often than the drug labels, while the drug claim is less than half as a claim. These facts are directly ‘safe’ and ‘effective’ primary marketing messages of drugs. Group.
The EPPA report claims that the bullet damages women, leading to 1 in 10 patients experience “severe adverse phenomena”, including bleeding, emergency chamber visits, and ectopic pregnancy.
The FDA Chief has no ‘plans’ to change the abortion pill policy, but the security review is going on
More than 20 Republican Attorney Generals are demanding that the Trump administration restore security protocols for abortion drug mifiprystone. (AP Photo/Alan G. Breed)
Letter under the leadership of Canasus Attorney General Chris Kobach, Kennedy comes after Junior. Makary asked to review the latest data of mifepristone and its safety.
“Based on the review, the FDA must consider restoring the security protocol, which was recently identified as 2011, which is in the release of a risk evaluation and mitigation strategy (Rames) for mifepristone, but was removed by Obama and Biden Administrations,” the letter should be said that the drug should be saved.
“Alternatively, in the light of severe risks for women, which is currently being prescribed this drug without significant safety measures, and in this event the FDA is unable to restore the 2011 security protocol for mifaprystone, the FDA should consider withdrawing the withdrawal of mifiprystone from the market until it can meet its review, which does not fulfill its review, which is objective and efficient and a single one can fulfill its review. But cannot decide. “
Sen Josh Hale, R-Mo., also sent a letter to Kennedy Junior last month, in which he urged to take immediate action to resume the security railing on Mifepristone after the secretary’s commitment to review the drug safety.
Kennedy Junior asked Makeri to review the latest data of Mifepristone and its safety. (Andrew Harnik/Getty Images)
Makri had earlier said that he had no plans to modify the policies around Mifiprystone, but if the FDA suggested that the data was suggested was the security issue.
Mifaprystone, which is taken with another drug called Misoprostol to end an early pregnancy, was first approved by the FDA in 2000 after “a completely and comprehensive review”, it was safe and effective, according to the agency’s website, which said that since its approval, periodic reviews have not identified new security concerns since its approval.
Last year, the Supreme Court rejected a challenge, targeting the availability of drug. The plaintiff had demanded a ban on access to mifaprystone across the country, including a Democrat -led state, where abortion is legal. The court did not rule on whether the FDA acted legally when he moved during the Obama and Biden administration, so that the rules for the use of mifepristone could be reduced which was established during the Clinton Administration.
According to a study by the Golotcher Institute, more than half of the abortion of all miscarriage in the US health care system in 2023 was created by miscarriage.
Medical Group FDA urges Kennedy that extensive approval of abortion drugs
The letter of 22 Attorney General was led by Census Attorney General Kobach. (AP Photo/John Hannah)
Click here to get Fox News app
The Attorney General wrote, “Currently, a woman can get a mifepristone abortion by participating in only one telehland with any approved healthcare provider (not necessarily a physician), ordering drugs through a mail-order pharmacy, and is self-promoting them,” The Attorney General wrote. “And the priscreber only needs to report an adverse event if he becomes aware that the patient has died.”
“In 2016 (and in 2023), the FDA was removed to remove these important security protocols that the FDA required five years ago the question arises as to whether the removal was inspired by other views other than the safety of patients … The dedication of the current FDA for the health and good of all Americans is encouraging.
